Neogen Co. (NEOG) Director James L. Herbert Sells 41,000 Shares
Neogen Co. (NASDAQ:NEOG) Director James L. Herbert sold 41,000 shares of the company’s stock in a transaction dated Thursday, April 18th. The stock was sold at an average price of $56.09, for a total value of $2,299,690.00. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
Shares of NASDAQ NEOG opened at $56.32 on Tuesday. Neogen Co. has a 1-year low of $50.60 and a 1-year high of $97.38. The stock has a market capitalization of $2.96 billion, a PE ratio of 46.55, a P/E/G ratio of 4.98 and a beta of 1.33.
Neogen (NASDAQ:NEOG) last issued its earnings results on Tuesday, March 26th. The company reported $0.25 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.27 by ($0.02). Neogen had a return on equity of 10.48% and a net margin of 14.96%. The company had revenue of $97.70 million during the quarter, compared to analysts’ expectations of $102.55 million. During the same period in the previous year, the company earned $0.32 EPS. Neogen’s quarterly revenue was up 3.0% on a year-over-year basis. As a group, research analysts expect that Neogen Co. will post 1.14 EPS for the current fiscal year.
NEOG has been the subject of several research analyst reports. BidaskClub upgraded Neogen from a “strong sell” rating to a “sell” rating in a research note on Wednesday, March 20th. ValuEngine lowered Neogen from a “buy” rating to a “hold” rating in a research note on Thursday, January 10th. Craig Hallum raised Neogen from a “hold” rating to a “buy” rating and set a $62.76 target price for the company in a research report on Tuesday, March 19th. Finally, Zacks Investment Research reaffirmed a “hold” rating on shares of Neogen in a research report on Monday, December 31st. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $62.76.
Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment primarily offers diagnostic test kits and complementary to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test for adenosine triphosphate, a chemical found in living cells.
Featured Story: How Do You Make Money With Penny Stocks?
Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.